Autophagy and cardiovascular aging: Lesson learned from rapamycin

Cell Cycle

Volumn 11, Issue 11, 2012, Pages 2092-2099

  Nair, Sreejayan ^a   Ren, Jun ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

Aging; Autophagy; Cardiovascular; mTOR; Rapamycin

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN;

AGING; AUTOPHAGY; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; DOWN REGULATION; EXERCISE; HUMAN; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

MAMMALIA;

EID: 84861917512     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.20317     Document Type: Review

References (101)

1. Lutz W, Sanderson W, Scherbov S. The coming acceleration of global population ageing. Nature 2008; 451:716-9; PMID:18204438; http://dx.doi.org/10. 1038/nature06516.
2. Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993; 73:413-67; PMID:8475195.
3. Boengler K, Schulz R, Heusch G. Loss of cardioprotection with ageing. Cardiovasc Res 2009; 83:247-61; PMID:19176601; http://dx.doi.org/10.1093/cvr/ cvp033.
4. Rich MW; Quality of Care Committee; Heart Failure Society of America. The year in quality of care in heart failure. J Card Fail 2011; 17:443-50; PMID:21624731; http://dx.doi.org/10.1016/j.cardfail.2011.04.003.
5. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011; 123:18-209; PMID:21160056; http://dx.doi.org/10.1161/CIR.0b013e3182009701.
6. Gajarsa JJ, Kloner RA. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms and therapeutic modalities. Heart Fail Rev 2011; 16:13-21; PMID:20623185; http://dx.doi.org/10.1007/s10741- 010-9181-7.
7. Jugdutt BI. Heart failure in the elderly: advances and challenges. Expert Rev Cardiovasc Ther 2010; 8:695-715; PMID:20450303; http://dx.doi.org/10.1586/ erc.10.36.
8. Dai Q, Escobar GP, Hakala KW, Lambert JM, Weintraub ST, Lindsey ML. The left ventricle proteome differentiates middle-aged and old left ventricles in mice. J Proteome Res 2008; 7:756-65; PMID:18166010; http://dx.doi.org/10.1021/ pr700685e.
9. Strait JB, Lakatta EG. Aging-associated cardiovascular changes and their relationship to heart failure. Heart Fail Clin 2012; 8:143-64; PMID:22108734; http://dx.doi.org/10.1016/j.hfc.2011.08.011.
10. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation 2003; 107:139-46; PMID:12515756; http://dx.doi.org/10.1161/01.CIR.0000048892.83521.58.
11. Yang X, Sreejayan N, Ren J. Views from within and beyond: narratives of cardiac contractile dysfunction under senescence. Endocrine 2005; 26:127-37; PMID:15888924; http://dx.doi.org/10.1385/ENDO:26:2:127.
12. Ferrari AU, Radaelli A, Centola M. Invited review: aging and the cardiovascular system. J Appl Physiol 2003; 95:2591-7; PMID:14600164.
13. Fleg JL, Shapiro EP, O'Connor F, Taube J, Goldberg AP, Lakatta EG. Left ventricular diastolic filling performance in older male athletes. JAMA 1995; 273:1371-5; PMID:7715063; http://dx.doi.org/10.1001/jama.1995.03520410065028.
14. Sussman MA, Anversa P. Myocardial aging and senescence: where have the stem cells gone? Annu Rev Physiol 2004; 66:29-48; PMID:14977395; http://dx.doi.org/10.1146/annurev.physiol.66.032102.140723.
15. Dhalla NS, Rangi S, Babick AP, Zieroth S, Elimban V. Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging. Heart Fail Rev 2011; In press; PMID:21850540; http://dx.doi.org/10.1007/s10741- 011-9278-7.
16. Lakatta EG. Cardiovascular aging research: the next horizons. J Am Geriatr Soc 1999; 47:613-25; PMID:10323658.
17. Yang Z, Klionsky DJ. An overview of the molecular mechanism of autophagy. Curr Top Microbiol Immunol 2009; 335:1-32; PMID:19802558; http://dx.doi.org/10. 1007/978-3-642-00302-8-1.
18. Cefalu CA. Theories and mechanisms of aging. Clin Geriatr Med 2011; 27:491-506; PMID:22062437; http://dx.doi.org/10.1016/j.cger.2011.07.001.
19. Jin K. Modern Biological Theories of Aging. Aging Dis 2010; 1:72-4; PMID:21132086.
20. Martin GM. The biology of aging: 1985-2010 and beyond. FASEB J 2011; 25:3756-62; PMID:22046003; http://dx.doi.org/10.1096/fj.11-1102.ufm.
21. Dai DF, Chen T, Johnson SC, Szeto HH, Rabinovitch PS. Cardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease. Antioxid Redox Signal 2012; In press; PMID:22229339; http://dx.doi.org/10.1089/ars.2011. 4179.
22. Chen Z, Siu B, Ho YS, Vincent R, Chua CC, Hamdy RC, et al. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol 1998; 30:2281-9; PMID:9925365; http://dx.doi.org/10. 1006/jmcc.1998.0789.
23. Fang CX, Doser TA, Yang X, Sreejayan N, Ren J. Metallothionein antagonizes aging-induced cardiac contractile dysfunction: role of PTP1B, insulin receptor tyrosine phosphorylation and Akt. Aging Cell 2006; 5:177-85; PMID:16626396; http://dx.doi.org/10.1111/j.1474-9726.2006.00201.x.
24. Ge W, Zhang Y, Han X, Ren J. Cardiac-specific overexpression of catalase attenuates paraquat-induced myocardial geometric and contractile alteration: role of ER stress. Free Radic Biol Med 2010; 49:2068-77; PMID:20937379; http://dx.doi.org/10.1016/j.freeradbiomed.2010.10.686.
25. Ren J, Li Q, Wu S, Li SY, Babcock SA. Cardiac overexpression of antioxidant catalase attenuates aging-induced cardiomyocyte relaxation dysfunction. Mech Ageing Dev 2007; 128:276-85; PMID:17250874; http://dx.doi.org/10.1016/j.mad.2006.12.007.
26. Smit AJ, Hartog JW, Voors AA, van Veldhuisen DJ. Advanced glycation endproducts in chronic heart failure. Ann NY Acad Sci 2008; 1126:225-30; PMID:18448821; http://dx.doi.org/10.1196/annals.1433.038.
27. Li SY, Du M, Dolence EK, Fang CX, Mayer GE, Ceylan-Isik AF, et al. Aging induces cardiac diastolic dysfunction, oxidative stress, accumulation of advanced glycation endproducts and protein modification. Aging Cell 2005; 4:57-64; PMID:15771609; http://dx.doi.org/10.1111/j.1474-9728.2005.00146.x.
28. Shih H, Lee B, Lee RJ, Boyle AJ. The aging heart and post-infarction left ventricular remodeling. J Am Coll Cardiol 2011; 57:9-17; PMID:21185495; http://dx.doi.org/10.1016/j.jacc.2010.08.623.
29. Judge S, Leeuwenburgh C. Cardiac mitochondrial bioenergetics, oxidative stress and aging. Am J Physiol Cell Physiol 2007; 292:1983-92; PMID:17344313; http://dx.doi.org/10.1152/ajpcell.00285.2006.
30. Wojtovich AP, Nadtochiy SM, Brookes PS, Nehrke K. Ischemic preconditioning: the role of mitochondria and aging. Exp Gerontol 2012; 47:1-7; PMID:22100642; http://dx.doi.org/10.1016/j.exger.2011.11.001.
31. Ago T, Matsushima S, Kuroda J, Zablocki D, Kitazono T, Sadoshima J. The NADPH oxidase Nox4 and aging in the heart. Aging (Albany NY) 2010; 2:1012-6; PMID:21212466.
32. Hafner AV, Dai J, Gomes AP, Xiao CY, Palmeira CM, Rosenzweig A, et al. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY) 2010; 2:914-23; PMID:21212461.
33. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 2000; 192:1001-14; PMID:11015441; http://dx.doi.org/10.1084/jem.192.7.1001.
34. Cesselli D, Beltrami AP, D'Aurizio F, Marcon P, Bergamin N, Toffoletto B, et al. Effects of age and heart failure on human cardiac stem cell function. Am J Pathol 2011; 179:349-66; PMID:21703415; http://dx.doi.org/10.1016/j.ajpath. 2011.03.036.
35. Wong LS, de Boer RA, Samani NJ, van Veldhuisen DJ, van der Harst P. Telomere biology in heart failure. Eur J Heart Fail 2008; 10:1049-56; PMID:18815070; http://dx.doi.org/10.1016/j.ejheart.2008.08.007.
36. Bodyak N, Kang PM, Hiromura M, Sulijoadikusumo I, Horikoshi N, Khrapko K, et al. Gene expression profiling of the aging mouse cardiac myocytes. Nucleic Acids Res 2002; 30:3788-94; PMID:12202764; http://dx.doi.org/10.1093/nar/gkf497.
37. Chu MW, Siegmund KD, Eckstam CL, Kim JY, Yang AS, Kanel GC, et al. Lack of increases in methylation at three CpG-rich genomic loci in non-mitotic adult tissues during aging. BMC Med Genet 2007; 8:50; PMID:17672908; http://dx.doi.org/10.1186/1471-2350-8-50.
38. Liu N, Olson EN. MicroRNA regulatory networks in cardiovascular development. Dev Cell 2010; 18:510-25; PMID:20412767; http://dx.doi.org/10.1016/ j.devcel.2010.03.010.
39. Enns LC, Pettan-Brewer C, Ladiges W. Protein kinase A is a target for aging and the aging heart. Aging (Albany NY) 2010; 2:238-43; PMID:20448293.
40. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290:1717-21; PMID:11099404; http://dx.doi.org/10. 1126/science.290.5497.1717.
41. Mizushima N. Autophagy: process and function. Genes Dev 2007; 21:2861-73; PMID:18006683; http://dx.doi.org/10.1101/gad.1599207.
42. Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol 2009; 10:458-67; PMID:19491929; http://dx.doi.org/10.1038/nrm2708.
43. Takemura G, Miyata S, Kawase Y, Okada H, Maruyama R, Fujiwara H. Autophagic degeneration and death of cardiomyocytes in heart failure. Autophagy 2006; 2:212-4; PMID:16874110.
44. Cuervo AM, Bergamini E, Brunk UT, Dröge W, Ffrench M, Terman A. Autophagy and aging: the importance of maintaining "clean" cells. Autophagy 2005; 1:131-40; PMID:16874025; http://dx.doi.org/10.4161/auto.1.3. 2017.
45. Vellai T. Autophagy genes and ageing. Cell Death Differ 2009; 16:94-102; PMID:19079287; http://dx.doi.org/10.1038/cdd.2008.126.
46. Alvers AL, Fishwick LK, Wood MS, Hu D, Chung HS, Dunn WA Jr, et al. Autophagy and amino acid homeostasis are required for chronological longevity in Saccharomyces cerevisiae. Aging Cell 2009; 8:353-69; PMID:19302372; http://dx.doi.org/10.1111/j.1474-9726.2009.00469.x.
47. Hars ES, Qi H, Ryazanov AG, Jin S, Cai L, Hu C, et al. Autophagy regulates ageing in C. elegans. Autophagy 2007; 3:93-5; PMID:17204841.
48. Simonsen A, Cumming RC, Brech A, Isakson P, Schubert DR, Finley KD. Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila. Autophagy 2008; 4:176-84; PMID:18059160.
49. Taneike M, Yamaguchi O, Nakai A, Hikoso S, Takeda T, Mizote I, et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy 2010; 6:600-6; PMID:20431347; http://dx.doi.org/10.4161/auto.6.5. 11947.
50. Tóth ML, Sigmond T, Borsos E, Barna J, Erdélyi P, Takács-Vellai K, et al. Longevity pathways converge on autophagy genes to regulate lifespan in Caenorhabditis elegans. Autophagy 2008; 4:330-8; PMID:18219227.
51. Zhang C, Cuervo AM. Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function. Nat Med 2008; 14:959-65; PMID:18690243; http://dx.doi.org/10.1038/nm.1851.
52. Goswami SK, Das DK. Autophagy in the myocardium: Dying for survival? Exp Clin Cardiol 2006; 11:183-8; PMID:18651029.
53. Sarkar S, Ravikumar B, Floto RA, Rubinsztein DC. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine- expanded huntingtin and related proteinopathies. Cell Death Differ 2009; 16:46-56; PMID:18636076; http://dx.doi.org/10.1038/cdd.2008.110.
54. Blagosklonny MV. Aging: ROS or TOR. Cell Cycle 2008; 7:3344-54; PMID:18971624; http://dx.doi.org/10.4161/cc.7.21.6965.
55. Kaeberlein M, Powers RW, 3rd, Steffen KK, Westman EA, Hu D, Dang N, et al. Regulation of yeast replicative lifespan by TOR and Sch9 in response to nutrients. Science 2005; 310:1193-6; PMID:16293764; http://dx.doi.org/10.1126/ science.1115535.
56. Gottlieb RA, Finley KD, Mentzer RM Jr. Cardioprotection requires taking out the trash. Basic Res Cardiol 2009; 104:169-80; PMID:19242643; http://dx.doi.org/10.1007/s00395-009-0011-9.
57. McCormick J, Knight RA, Barry SP, Scarabelli TM, Abounit K, Latchman DS, et al. Autophagy in the stress-induced myocardium. Front Biosci (Elite Ed) 2012; 4:2131-41; PMID:22202025; http://dx.doi.org/10.2741/530.
58. Gustafsson AB, Gottlieb RA. Autophagy in ischemic heart disease. Circ Res 2009; 104:150-8; PMID:19179668; http://dx.doi.org/10.1161/CIRCRESAHA.108. 187427.
59. Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, Massover WH, et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA 2005; 102:13807-12; PMID:16174725; http://dx.doi.org/10.1073/pnas.0506843102.
60. Zhang D, Contu R, Latronico MV, Zhang J, Rizzi R, Catalucci D, et al. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest 2010; 120:2805-16; PMID:20644257; http://dx.doi.org/10. 1172/JCI43008.
61. Rothermel BA, Hill JA. Autophagy in load-induced heart disease. Circ Res 2008; 103:1363-9; PMID:19059838; http://dx.doi.org/10.1161/CIRCRESAHA.108. 186551.
62. Tanaka Y, Guhde G, Suter A, Eskelinen EL, Hartmann D, Lüllmann-Rauch R, et al. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 2000; 406:902-6; PMID:10972293; http://dx.doi.org/10.1038/35022595.
63. Kostin S, Pool L, Elsässer A, Hein S, Drexler HC, Arnon E, et al. Myocytes die by multiple mechanisms in failing human hearts. Circ Res 2003; 92:715-24; PMID:12649263; http://dx.doi.org/10.1161/01.RES.0000067471.95890.5C.
64. Zheng Q, Su H, Tian Z, Wang X. Proteasome malfunction activates macroautophagy in the heart. Am J Cardiovasc Dis 2011; 1:214-26; PMID:22081794.
65. Vigliano CA, Cabeza Meckert PM, Diez M, Favaloro LE, Cortés C, Fazzi L, et al. Cardiomyocyte hypertrophy, oncosis and autophagic vacuolization predict mortality in idiopathic dilated cardiomyopathy with advanced heart failure. J Am Coll Cardiol 2011; 57:1523-31; PMID:21453830; http://dx.doi.org/ 10.1016/j.jacc.2010.09.080.
66. Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 2007; 13:619-24; PMID:17450150; http://dx.doi.org/ 10.1038/nm1574.
67. Balasubramanian S, Johnston RK, Moschella PC, Mani SK, Tuxworth WJ Jr, Kuppuswamy D. mTOR in growth and protection of hypertrophying myocardium. Cardiovasc Hematol Agents Med Chem 2009; 7:52-63; PMID:19149544; http://dx.doi.org/10.2174/187152509787047603.
68. Weichhart T. Mammalian target of rapamycin: a signaling kinase for every aspect of cellular life. Methods Mol Biol 2012; 821:1-14; PMID:22125056; http://dx.doi.org/10.1007/978-1-61779-430-8-1.
69. Glazer HP, Osipov RM, Clements RT, Sellke FW, Bianchi C. Hypercholesterolemia is associated with hyperactive cardiac mTORC1 and mTORC2 signaling. Cell Cycle 2009; 8:1738-46; PMID:19395857; http://dx.doi.org/10.4161/ cc.8.11.8619.
70. Powers RW, 3rd, Kaeberlein M, Caldwell SD, Kennedy BK, Fields S. Extension of chronological lifespan in yeast by decreased TOR pathway signaling. Genes Dev 2006; 20:174-84; PMID:16418483; http://dx.doi.org/10.1101/gad. 1381406.
71. Vellai T, Takacs-Vellai K, Zhang Y, Kovacs AL, Orosz L, Müller F. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 2003; 426:620; PMID:14668850; http://dx.doi.org/10.1038/426620a.
72. Kapahi P, Zid BM, Harper T, Koslover D, Sapin V, Benzer S. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol 2004; 14:885-90; PMID:15186745; http://dx.doi.org/10.1016/j.cub.2004.03. 059.
73. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009; 460:392-5; PMID:19587680.
74. Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, et al. Rapamycin, but not resveratrol or simvastatin, extends lifespan of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 2011; 66:191-201; PMID:20974732; http://dx.doi.org/10.1093/gerona/glq178.
75. Chen C, Liu Y, Liu Y, Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci Signal 2009; 2:75; PMID:19934433; http://dx.doi.org/10.1126/scisignal.2000559.
76. Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV, Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell Cycle 2009; 8:1888-95; PMID:19471117; http://dx.doi.org/10.4161/cc.8.12.8606.
77. Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, et al. Rapamycin extends maximal lifespan in cancer-prone mice. Am J Pathol 2010; 176:2092-7; PMID:20363920; http://dx.doi.org/10.2353/ajpath.2010. 091050.
78. Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, et al. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle 2011; 10:4230-6; PMID:22107964; http://dx.doi.org/10.4161/cc.10.24.18486.
79. Menendez JA, Vellon L, Oliveras-Ferraros C, Cufí S, Vazquez-Martin A. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging. Cell Cycle 2011; 10:3658-77; PMID:22052357; http://dx.doi.org/10.4161/ cc.10.21.18128.
80. Blagosklonny MV. Calorie restriction: decelerating mTOR-driven aging from cells to organisms (including humans). Cell Cycle 2010; 9:683-8; PMID:20139716; http://dx.doi.org/10.4161/cc.9.4.10766.
81. Hua Y, Zhang Y, Ceylan-Isik AF, Wold LE, Nunn JM, Ren J. Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy. Basic Res Cardiol 2011; 106:1173-91; PMID:21901288; http://dx.doi.org/10.1007/s00395-011-0222-8.
82. Selman C, Tullet JM, Wieser D, Irvine E, Lingard SJ, Choudhury AI, et al. Ribosomal protein S6 kinase 1 signaling regulates mammalian lifespan. Science 2009; 326:140-4; PMID:19797661; http://dx.doi.org/10.1126/science.1177221.
83. Bjedov I, Toivonen JM, Kerr F, Slack C, Jacobson J, Foley A, et al. Mechanisms of lifespan extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab 2010; 11:35-46; PMID:20074526; http://dx.doi.org/10. 1016/j.cmet.2009.11.010.
84. Pan KZ, Palter JE, Rogers AN, Olsen A, Chen D, Lithgow GJ, et al. Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans. Aging Cell 2007; 6:111-9; PMID:17266680; http://dx.doi.org/10.1111/j.1474-9726.2006. 00266.x.
85. Beugnet A, Tee AR, Taylor PM, Proud CG. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability. Biochem J 2003; 372:555-66; PMID:12611592; http://dx.doi.org/10. 1042/BJ20021266.
86. Yu L, McPhee CK, Zheng L, Mardones GA, Rong Y, Peng J, et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010; 465:942-6; PMID:20526321; http://dx.doi.org/10.1038/nature09076.
87. Chan EY, Tooze SA. Evolution of Atg1 function and regulation. Autophagy 2009; 5:758-65; PMID:19411825.
88. Mizushima N. The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin Cell Biol 2010; 22:132-9; PMID:20056399; http://dx.doi.org/10.1016/j. ceb.2009.12.004.
89. Anderson RM, Weindruch R. Metabolic reprogramming, caloric restriction and aging. Trends Endocrinol Metab 2010; 21:134-41; PMID:20004110; http://dx.doi.org/10.1016/j.tem.2009.11.005.
90. Han X, Ren J. Caloric restriction and heart function: is there a sensible link? Acta Pharmacol Sin 2010; 31:1111-7; PMID:20729873; http://dx.doi.org/10. 1038/aps.2010.146.
91. Madeo F, Tavernarakis N, Kroemer G. Can autophagy promote longevity? Nat Cell Biol 2010; 12:842-6; PMID:20811357; http://dx.doi.org/10.1038/ncb0910-842.
92. Wohlgemuth SE, Julian D, Akin DE, Fried J, Toscano K, Leeuwenburgh C, et al. Autophagy in the heart and liver during normal aging and calorie restriction. Rejuvenation Res 2007; 10:281-92; PMID:17665967; http://dx.doi.org/10.1089/rej.2006.0535.
93. Shinmura K, Tamaki K, Sano M, Murata M, Yamakawa H, Ishida H, et al. Impact of long-term caloric restriction on cardiac senescence: caloric restriction ameliorates cardiac diastolic dysfunction associated with aging. J Mol Cell Cardiol 2011; 50:117-27; PMID:20977912; http://dx.doi.org/10.1016/j. yjmcc.2010.10.018.
94. Malik SA, Mariño G, BenYounès A, Shen S, Harper F, Maiuri MC, et al. Neuroendocrine regulation of autophagy by leptin. Cell Cycle 2011; 10:2917-23; PMID:21857156; http://dx.doi.org/10.4161/cc.10.17.17067.
95. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, et al. Autophagy regulates lipid metabolism. Nature 2009; 458:1131-5; PMID:19339967; http://dx.doi.org/10.1038/nature07976.
96. Shibata M, Yoshimura K, Furuya N, Koike M, Ueno T, Komatsu M, et al. The MAP1-LC3 conjugation system is involved in lipid droplet formation. Biochem Biophys Res Commun 2009; 382:419-23; PMID:19285958; http://dx.doi.org/10.1016/j. bbrc.2009.03.039.
97. Inuzuka Y, Okuda J, Kawashima T, Kato T, Niizuma S, Tamaki Y, et al. Suppression of phosphoinositide-3-kinase prevents cardiac aging in mice. Circulation 2009; 120:1695-703; PMID:19822807; http://dx.doi.org/10.1161/ CIRCULATIONAHA.109.871137.
98. Shende P, Plaisance I, Morandi C, Pellieux C, Berthonneche C, Zorzato F, et al. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression and causes heart failure in mice. Circulation 2011; 123:1073-82; PMID:21357822; http://dx.doi.org/10.1161/CIRCULATIONAHA.110.977066.
99. McMullen JR, Sherwood MC, Tarnavski O, Zhang L, Dorfman AL, Shioi T, et al. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation 2004; 109:3050-5; PMID:15184287; http://dx.doi.org/10.1161/01.CIR.0000130641.08705.45.
100. Shioi T, McMullen JR, Tarnavski O, Converso K, Sherwood MC, Manning WJ, et al. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 2003; 107:1664-70; PMID:12668503; http://dx.doi.org/10.1161/01.CIR. 0000057979.36322.88.
101. Hiemann NE, Wellnhofer E, Lehmkuhl HB, Knosalla C, Hetzer R, Meyer R. Everolimus prevents endomyocardial remodeling after heart transplantation. Transplantation 2011; 92:1165-72; PMID:21956201; http://dx.doi.org/10.1097/TP. 0b013e3182332886.